Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 8
Results: 42
Positive progress for non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: A novel targeted therapy option.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2007, doi. 10.1177/10781552211044980
- By:
- Publication type:
- Article
Cost-effectiveness of immune checkpoint inhibitors and radiotherapy in advanced non-small cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2004, doi. 10.1177/10781552211038925
- By:
- Publication type:
- Article
Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1993, doi. 10.1177/10781552211038309
- By:
- Publication type:
- Article
Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2057, doi. 10.1177/10781552211017960
- By:
- Publication type:
- Article
Cost-effectiveness of denosumab in preventing skeletal-related events in bone metastases.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2000, doi. 10.1177/10781552211038002
- By:
- Publication type:
- Article
Alternate dosage formulations of oral targeted anticancer agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1963, doi. 10.1177/10781552211037976
- By:
- Publication type:
- Article
Defining cytotoxic drugs – you know it when you see it?
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1958, doi. 10.1177/10781552211034473
- By:
- Publication type:
- Article
Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2066, doi. 10.1177/10781552211033009
- By:
- Publication type:
- Article
A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2061, doi. 10.1177/10781552211017977
- By:
- Publication type:
- Article
Novel agents for myelodysplastic syndromes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1982, doi. 10.1177/10781552211037993
- By:
- Publication type:
- Article
Adjuvant pembrolizumab in genomically selected high-risk patients with muscle-invasive bladder cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2053, doi. 10.1177/10781552211016526
- By:
- Publication type:
- Article
Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2049, doi. 10.1177/10781552211016081
- By:
- Publication type:
- Article
Ifosfamide-related encephalopathy with severe clinical presentations in children with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2018, doi. 10.1177/10781552211005533
- By:
- Publication type:
- Article
Blinatumomab-related pneumatosis intestinalis in a pediatric patient with relapsed acute lymphoblastic leukemia: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2045, doi. 10.1177/10781552211015776
- By:
- Publication type:
- Article
A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2010, doi. 10.1177/10781552211004698
- By:
- Publication type:
- Article
Patterns of complementary and alternative medicine use among Tunisian cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1948, doi. 10.1177/1078155220980131
- By:
- Publication type:
- Article
Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2035, doi. 10.1177/10781552211012782
- By:
- Publication type:
- Article
Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2030, doi. 10.1177/10781552211008223
- By:
- Publication type:
- Article
Trastuzumab-emtansine induced pleural and pericardial effusions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2041, doi. 10.1177/10781552211015772
- By:
- Publication type:
- Article
Motor "freezing" with oxaliplatin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2014, doi. 10.1177/10781552211004985
- By:
- Publication type:
- Article
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2027, doi. 10.1177/10781552211007889
- By:
- Publication type:
- Article
Ribociclib induced acute kidney injury: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 2023, doi. 10.1177/10781552211007202
- By:
- Publication type:
- Article
Results of a pre-implementation analysis of Ethiopia's National Pediatric Cancer Registry.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1940, doi. 10.1177/1078155220980051
- By:
- Publication type:
- Article
Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1936, doi. 10.1177/1078155220979046
- By:
- Publication type:
- Article
Small bowel wall edema induced by regorafenib is associated with regorafenib intolerance and shorter survival in patients with metastatic colorectal cancer: A retrospective study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1929, doi. 10.1177/1078155220978471
- By:
- Publication type:
- Article
Retrospective analysis of the incidence and severity of acute kidney injury (AKI) in patients with head and neck cancer receiving weekly cisplatin with radiotherapy (RAISe-AKI).
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1923, doi. 10.1177/1078155220978454
- By:
- Publication type:
- Article
Rapid rituximab infusion is safe and well tolerated in malignant and benign disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1919, doi. 10.1177/1078155220978450
- By:
- Publication type:
- Article
How human activity impacted manufacturing non-compliances: A multivariate analysis in a centralized cytotoxic preparation unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1896, doi. 10.1177/1078155220973065
- By:
- Publication type:
- Article
Unmet supportive care needs and determinants among cancer patients treated at University of Gondar Specialized Hospital, Northwest Ethiopia: A prospective cross-sectional study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1869, doi. 10.1177/1078155220971035
- By:
- Publication type:
- Article
Improving direct pharmacist counseling rates for oral oncolytic medications at an outpatient oncology clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1861, doi. 10.1177/1078155220971022
- By:
- Publication type:
- Article
Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1853, doi. 10.1177/1078155220970621
- By:
- Publication type:
- Article
Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1914, doi. 10.1177/1078155220977898
- By:
- Publication type:
- Article
Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1842, doi. 10.1177/1078155220970616
- By:
- Publication type:
- Article
Impact of the implementation of a pharmacist-driven immunosuppression drug monitoring protocol for hematopoietic stem cell transplant recipients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1907, doi. 10.1177/1078155220975088
- By:
- Publication type:
- Article
International usage of an English language oncology pharmacy podcast.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1904, doi. 10.1177/1078155220973721
- By:
- Publication type:
- Article
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1835, doi. 10.1177/1078155220970608
- By:
- Publication type:
- Article
Incidence of ifosfamide induced encephalopathy in patients receiving concomitant fosaprepitant.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1891, doi. 10.1177/1078155220971794
- By:
- Publication type:
- Article
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1883, doi. 10.1177/1078155220971751
- By:
- Publication type:
- Article
Reducing chemotherapy administration time on an inpatient oncology unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1878, doi. 10.1177/1078155220971737
- By:
- Publication type:
- Article
Impact of embedded medication assistance program specialists on medication access in outpatient oncology clinics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1829, doi. 10.1177/1078155220970269
- By:
- Publication type:
- Article
Implementation of a pharmacy consult service for evaluation of immune checkpoint inhibitor related adverse events at a large community hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1821, doi. 10.1177/1078155220970266
- By:
- Publication type:
- Article
Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 8, p. 1815, doi. 10.1177/1078155220969797
- By:
- Publication type:
- Article